Failure to Assess Self-Administration of Bedside Medications
Summary
The facility failed to conduct an assessment to determine whether a resident could safely self-administer medications. Resident #55 was admitted with diagnoses including acute kidney failure, cerebral infarction, and allergic contact dermatitis. The admission MDS identified intact cognition, frequent bowel incontinence, occasional bladder incontinence, and dependence on staff for bathing, lower body dressing, and putting on/taking off footwear. The care plan identified a self-care performance deficit due to weakness and directed staff to encourage the resident to participate to the fullest extent possible. Review of the hospital discharge summary showed active medications including Efinaconazole 10% solution and Ammonium Lactate 12%. A physician order was present for Ammonium Lactate to be applied over the whole body every evening, but the physician order record for the reviewed period did not identify an order for Efinaconazole. During observation, a box labeled Jublia was found on the resident’s bedside table, along with two bottles of Ammonium Lactate, one on the dresser and one inside a wash basin. The resident stated both medications were brought from home, that the resident had been using Jublia for several years, and that the resident applied both topical medications without staff assistance. The clinical record did not contain documentation related to Efinaconazole, an assessment showing the resident could safely self-administer it, or where it would be stored. Interviews showed staff were aware that residents who self-administer medications were supposed to be assessed and that outside medications were generally not to be kept at the bedside. RN #6 stated residents approved to self-administer would need a physician order and that medications brought from home would be labeled and kept locked in the medication cart, not at the bedside. APRN #1 and the DNS were not aware the resident was self-administering Efinaconazole or that it was at the bedside, and both stated they were not familiar with the medication at the time. RN #6 later completed an assessment and determined the resident could safely self-administer, updated the care plan, and had the resident sign a contraband notification form; a subsequent physician order then directed Efinaconazole to the toes once daily and allowed self-administration. The DNS later stated she had noted Efinaconazole on the discharge summary and reviewed it with APRN #1, but this was not documented in the resident’s clinical record.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.